References | CAYSTON® (aztreonam for inhalation solution)

  1. Pseudomonas. Cystic Fibrosis Foundation website. https://www.cff.org/Life-With-CF/Daily-Life/Germs-and-Staying-Healthy/What-Are-Germs/Pseudomonas/. Accessed January 13, 2017.
  2. Cunningham JC, Taussig LM. Respiratory System. In: An Introduction to Cystic Fibrosis: For Patients and Their Families. 6th ed. Cystic Fibrosis Foundation; 2013:41-58.
  3. Cystic Fibrosis. US National Library of Medicine website. https://ghr.nlm.nih.gov/condition/cystic-fibrosis. Updated January 24, 2017. Accessed January 29, 2017.
  4. Mogayzel PJ Jr, Naureckas ET, Robinson KA, et al. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013;187:680-689.
  5. Pritt B, O'Brien L, Winn W. Mucoid Pseudomonas in cystic fibrosis. Am J Clin Pathol. 2007;128:32-34.
  6. Cystic Fibrosis Foundation Patient Registry. 2016 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation; 2017. https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2016-Patient-Registry-Annual-Data-Report.pdf. Accessed October 8, 2018.
  7. Basics of lung care. Cystic Fibrosis Foundation website. https://www.cff.org/Living-with-CF/Treatments-and-Therapies/Airway-Clearance/Basics-of-Lung-Care. Accessed October 20, 2015.
  8. Cystic fibrosis. National Heart, Lung, and Blood Institute website.https://www.nhlbi.nih.gov/health-topics/cystic-fibrosis. Accessed October 20, 2015.
  9. Retsch-Bogart GZ, Quittner AL, Gibson RL, et al. Efficacy and safety of inhaled aztreonam lysine for airway Pseudomonas in cystic fibrosis. Chest. 2009;135:1223-1232.
  10. Data on file, Gilead Sciences, Inc.